Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

815 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trial watch: Dendritic cell-based interventions for cancer therapy.
Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: eggermont a. Oncoimmunology. 2012 Oct 1;1(7):1111-1134. doi: 10.4161/onci.21494. Oncoimmunology. 2012. PMID: 23170259 Free PMC article.
Trial Watch: Immunotherapy plus radiation therapy for oncological indications.
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: eggermont a. Oncoimmunology. 2016 Jul 25;5(9):e1214790. doi: 10.1080/2162402X.2016.1214790. eCollection 2016. Oncoimmunology. 2016. PMID: 27757313 Free PMC article. Review.
Trial Watch: Adoptive cell transfer immunotherapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: eggermont a. Oncoimmunology. 2012 May 1;1(3):306-315. doi: 10.4161/onci.19549. Oncoimmunology. 2012. PMID: 22737606 Free PMC article.
Trial Watch: Immunostimulatory cytokines.
Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: eggermont a. Oncoimmunology. 2012 Jul 1;1(4):493-506. doi: 10.4161/onci.20459. Oncoimmunology. 2012. PMID: 22754768 Free PMC article.
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: eggermont a. Oncoimmunology. 2012 Aug 1;1(5):699-716. doi: 10.4161/onci.20696. Oncoimmunology. 2012. PMID: 22934262 Free PMC article.
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: eggermont a. Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931. Oncoimmunology. 2012. PMID: 23162757 Free PMC article.
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.
Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Senovilla L, et al. Among authors: eggermont a. Oncoimmunology. 2012 Nov 1;1(8):1323-1343. doi: 10.4161/onci.22009. Oncoimmunology. 2012. PMID: 23243596 Free PMC article.
Trial watch: Peptide vaccines in cancer therapy.
Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: eggermont a. Oncoimmunology. 2012 Dec 1;1(9):1557-1576. doi: 10.4161/onci.22428. Oncoimmunology. 2012. PMID: 23264902 Free PMC article.
Trial watch: Monoclonal antibodies in cancer therapy.
Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: eggermont a. Oncoimmunology. 2013 Jan 1;2(1):e22789. doi: 10.4161/onci.22789. Oncoimmunology. 2013. PMID: 23482847 Free PMC article.
815 results